SCHEMBL14083573

SCHEMBL14083573

COc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)cc2F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 4/20 0.57
▸ TOP1 P11387 1/20 0.52
▸ MAPT P10636 5/20 0.52
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ GAA P10253 1/20 0.52
▸ RAB9A P51151 3/20 0.51
▸ NPC1 O15118 3/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ PKM P14618 1/20 0.51
▸ TYK2 P29597 2/20 0.50
▸ JAK2 O60674 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ STIM1 Q13586 1/20 0.48
▸ ORAI1 Q96D31 1/20 0.48
▸ PPARG P37231 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ NCOR2 Q9Y618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083590 0.90 RAB9A (0.57) TRPV1MAPTMEN1KMT2AGAA
SCHEMBL14082764 0.88 TRPV1 (0.62) TRPV1MEN1KMT2ARAB9ANPC1
SCHEMBL14083594 0.88 NPC1 (0.63) TRPV1MAPTMEN1KMT2ARAB9A
SCHEMBL14083623 0.87 TRPV1 (0.52) TRPV1MAPTMEN1KMT2ARAB9A
SCHEMBL14083572 0.87 TRPV1 (0.60) TRPV1PPARG
SCHEMBL14083604 0.86 TRPV1 (0.58) TRPV1MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL14083575 0.86 TRPV1 (0.62) TRPV1TYK2JAK2HTT
SCHEMBL14083607 0.86 TRPV1 (0.58) TRPV1MAPT
SCHEMBL14083602 0.85 TRPV1 (0.71) TRPV1MAPTGAARAB9ANPSR1
SCHEMBL14083629 0.84 NPC1 (0.58) TRPV1MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885TOP1 4833/4885MAPT 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback